MY184940A - Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent - Google Patents
Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agentInfo
- Publication number
- MY184940A MY184940A MYPI2011700079A MYPI2011700079A MY184940A MY 184940 A MY184940 A MY 184940A MY PI2011700079 A MYPI2011700079 A MY PI2011700079A MY PI2011700079 A MYPI2011700079 A MY PI2011700079A MY 184940 A MY184940 A MY 184940A
- Authority
- MY
- Malaysia
- Prior art keywords
- rhinocerus
- lignosus
- tiger
- inflammatory agent
- milk mushroom
- Prior art date
Links
- 235000001674 Agaricus brunnescens Nutrition 0.000 title abstract 2
- 241000208566 Lignosus rhinocerotis Species 0.000 title 1
- 229940121363 anti-inflammatory agent Drugs 0.000 title 1
- 239000002260 anti-inflammatory agent Substances 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention is to provide a novel anti-inflammatory compound which has excellent anti-inflammatory activity with reduced side effects and which can be prepared starting with a medicinal mushroom used in functional food, nutraceutical or pharmaceutical formulation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2011700079A MY184940A (en) | 2011-06-01 | 2011-06-01 | Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2011700079A MY184940A (en) | 2011-06-01 | 2011-06-01 | Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY184940A true MY184940A (en) | 2021-04-30 |
Family
ID=80001620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011700079A MY184940A (en) | 2011-06-01 | 2011-06-01 | Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY184940A (en) |
-
2011
- 2011-06-01 MY MYPI2011700079A patent/MY184940A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501421A1 (en) | Long-acting formulations of insulin | |
| MX2015008627A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| CO6771409A2 (en) | Substituted 1-benzylcycloalkylcarboxylic acids and their use | |
| WO2013170068A3 (en) | Nuclear transport modulators and uses thereof | |
| IN2014DN06104A (en) | ||
| IL231170A (en) | Nitrogen mustard derivative compound, a pharmaceutical composition, use of the compound in the preparation of a medicament and the compound for use as medicament | |
| PH12015500900B1 (en) | A stabilized pemetrexed formulation | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| MX366090B (en) | Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients. | |
| MX340147B (en) | Pharmaceutical and nutraceutical compositions of abscisic acid. | |
| TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| MX349373B (en) | Novel pyrazine derivatives. | |
| CO7160080A2 (en) | Lipid compositions of racecadot | |
| WO2012074830A3 (en) | Modified release tranexamic acid formulation | |
| AU2012345659A8 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| WO2012093973A3 (en) | Compositions in the form of tablets comprising acarbose | |
| MX344189B (en) | Formulations of mazindol. | |
| UA105944C2 (en) | Drug formulation with theobromine and decongestant for treatment of cough | |
| MX356373B (en) | Compositions comprising antibacterial agent and tazobactam. | |
| NZ717192A (en) | Anti-inflammatory tripeptides | |
| MX355719B (en) | Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum. | |
| MX2014006201A (en) | Imatinib solid dosage forms reconstituted just before use. | |
| WO2013064388A3 (en) | Cosmetic formulation containing n-acyl-phytosphingosine | |
| MX2013010947A (en) | Gallium complexes, pharmaceutical compositions and methods of use. | |
| IN2015DN00962A (en) |